TY - JOUR T1 - COVID-19 challenges to dentistry in the new pandemic epicenter: Brazil JF - medRxiv DO - 10.1101/2020.06.11.20128744 SP - 2020.06.11.20128744 AU - Rafael R. Moraes AU - Marcos B. Correa AU - Ana B. Queiroz AU - Ândrea Daneris AU - João P. Lopes AU - Tatiana Pereira-Cenci AU - Otávio P. D’Avila AU - Maximiliano S. Cenci AU - Giana S. Lima AU - Flávio F. Demarco Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/14/2020.06.11.20128744.abstract N2 - A nationwide survey of dentists was carried out in Brazil, a new pandemic epicenter, to analyze how dental coverage has been affected (public versus private networks), changes in routine and burdens, and how the local prevalence of COVID-19 affects dental professionals. Dentists were recruited via email and an Instagram® campaign. Responses to an online questionnaire were collected May 15–24, 2020. COVID-19 case/death counts in the state where respondents work was used to test associations between contextual status and decreases in weekly appointments, fear of contracting COVID-19 at work, and current work status (α=0.05). Over 10 days, 3,122 responses were received, with region, gender, and age distributions similar to those of dentists in Brazil. Work status was affected for 94% of dentists, with less developed regions being more impacted. The impact on routine was high or very high for 84%, leading to varied changes to clinic infrastructure, personal protective equipment use, patient screening, and increased costs. COVID-19 patients had been seen by 5.3% of respondents, and 90% reported fearing contracting COVID-19 at work. Multilevel statistics showed that greater case and death rates (1000 cases or 100 deaths/million inhabitants) in one’s state increased the odds of being fearful of contracting the disease (by 18% and 25%). For each additional 1000 cases or 100 deaths, the odds of currently not working or treating emergencies increased by 36% and 58%. The reduction in patients seen weekly per dentist was greater in public (38.7±18.6) than in private clinics (22.5±17.8). This study provides early evidence of three major impacts of the pandemic on dentistry in Brazil: increasing inequalities due to coverage differences between public and private networks; adoption of new clinical routines, which are associated with an economic burden; and associations of regional COVID-19 incidence and mortality with fear of contracting the disease at work.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis survey research was approved by the Institutional Review Board through an online Brazilian system for review of ethical aspects. Due to urgency of the topic, the research protocol was later published in OSF in its original Portuguese form.Clinical Protocols https://osf.io/dnbgs/ Funding StatementThis study was financed by Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), Brazil (PRONEX 16/2551-0000471-4), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (Finance Code 001) and CAPES/PRINT (88881.309861/2018-01). The sponsors had no role in study design, collection, analysis or interpretation of data, writing the report, or decision to submit for publication. We thank the Brazilian Ministry of Health for providing the contact of professionals from the public network. We also thank all persons who helped to disseminate the campaign on Instagram and dentists who volunteered to participate.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Institutional Review Board (Federal University of Pelotas) in May 8, 2020 (protocol #4.015.536).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUnderlying research materials related to this paper can be accessed in OSF: doi:10.17605/OSF.IO/DNBGS https://osf.io/dnbgs/ ER -